Systematic review and meta-analysis of the prognostic significance of microRNAs in cervical cancer
In this meta-analysis, we analyzed case-control studies that assessed the prognostic potential of miRNAs in cervical cancer. We comprehensively searched EMBASE and PubMed databases and enrolled seven studies with 445 cervical cancer cases. A fixed effects model was used to calculate pooled hazard ratios (HRs) and associated 95% confidence intervals (95% CIs) from the overall survival (OS) data. Our analysis showed that poor OS in cervical cancer was associated with low miR-125 expression (HR = 1.61, 95% CI: 1.02-2.55, P = 0.042; I2 = 10.1%, P = 0.292; n = 99), low miR-145 expression (HR = 1.70, 95% CI: 1.29-2.24, P < 0.001; I2 = 0%, P = 0.560; n = 193) and high miR-196 expression (HR = 0.28, 95% CI: 0.15-0.52, P < 0.001; I2 = 0%, P = 0.950, n = 197). This makes microRNAs such as miR-125, miR-145 and miR-196 potential prognostic biomarkers in cervical cancer.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
Oncotarget - 9(2018), 24 vom: 30. März, Seite 17141-17148 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chen, Zhilan [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 20.11.2019 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.18632/oncotarget.23839 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM283301341 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM283301341 | ||
003 | DE-627 | ||
005 | 20231225040341.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.18632/oncotarget.23839 |2 doi | |
028 | 5 | 2 | |a pubmed24n0944.xml |
035 | |a (DE-627)NLM283301341 | ||
035 | |a (NLM)29682211 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chen, Zhilan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Systematic review and meta-analysis of the prognostic significance of microRNAs in cervical cancer |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 20.11.2019 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a In this meta-analysis, we analyzed case-control studies that assessed the prognostic potential of miRNAs in cervical cancer. We comprehensively searched EMBASE and PubMed databases and enrolled seven studies with 445 cervical cancer cases. A fixed effects model was used to calculate pooled hazard ratios (HRs) and associated 95% confidence intervals (95% CIs) from the overall survival (OS) data. Our analysis showed that poor OS in cervical cancer was associated with low miR-125 expression (HR = 1.61, 95% CI: 1.02-2.55, P = 0.042; I2 = 10.1%, P = 0.292; n = 99), low miR-145 expression (HR = 1.70, 95% CI: 1.29-2.24, P < 0.001; I2 = 0%, P = 0.560; n = 193) and high miR-196 expression (HR = 0.28, 95% CI: 0.15-0.52, P < 0.001; I2 = 0%, P = 0.950, n = 197). This makes microRNAs such as miR-125, miR-145 and miR-196 potential prognostic biomarkers in cervical cancer | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a cervical cancer | |
650 | 4 | |a meta-analysis | |
650 | 4 | |a miRNA | |
650 | 4 | |a prognosis | |
700 | 1 | |a Han, Yingyan |e verfasserin |4 aut | |
700 | 1 | |a Song, Chengwen |e verfasserin |4 aut | |
700 | 1 | |a Wei, Huafang |e verfasserin |4 aut | |
700 | 1 | |a Chen, Ying |e verfasserin |4 aut | |
700 | 1 | |a Huang, Kecheng |e verfasserin |4 aut | |
700 | 1 | |a Li, Shuang |e verfasserin |4 aut | |
700 | 1 | |a Ma, Ding |e verfasserin |4 aut | |
700 | 1 | |a Wang, Shixuan |e verfasserin |4 aut | |
700 | 1 | |a Wang, Jing |e verfasserin |4 aut | |
700 | 1 | |a Lu, Qiping |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Oncotarget |d 2010 |g 9(2018), 24 vom: 30. März, Seite 17141-17148 |w (DE-627)NLM199620113 |x 1949-2553 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2018 |g number:24 |g day:30 |g month:03 |g pages:17141-17148 |
856 | 4 | 0 | |u http://dx.doi.org/10.18632/oncotarget.23839 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2018 |e 24 |b 30 |c 03 |h 17141-17148 |